doi: 10.1056/NEJMsb020574.
Risks and benefits of activated protein C treatment for severe sepsis
Affiliations
- PMID: 12324562
- DOI: 10.1056/NEJMsb020574
Item in Clipboard
Risks and benefits of activated protein C treatment for severe sepsis
N Engl J Med.
.
No abstract available
Comment in
-
Treating sepsis.N Engl J Med. 2002 Sep 26;347(13):966-7. doi: 10.1056/NEJMp020096. N Engl J Med. 2002. PMID: 12324551 No abstract available.
-
Activated protein C for severe sepsis.N Engl J Med. 2002 Sep 26;347(13):1035-6. doi: 10.1056/NEJM200209263471315. N Engl J Med. 2002. PMID: 12324564 No abstract available.
Similar articles
-
Assessing the use of activated protein C in the treatment of severe sepsis.N Engl J Med. 2002 Sep 26;347(13):1030-4. doi: 10.1056/NEJMsb021512. N Engl J Med. 2002. PMID: 12324563 No abstract available.
-
Severe sepsis and therapy with activated protein C.N Engl J Med. 2005 Sep 29;353(13):1398-400. doi: 10.1056/NEJMe058160. N Engl J Med. 2005. PMID: 16192486 No abstract available.
-
Prescribing indications based on successful clinical trials in sepsis: a difficult exercise.Crit Care Med. 2006 Feb;34(2):525-9. doi: 10.1097/01.ccm.0000198329.85851.8e. Crit Care Med. 2006. PMID: 16424736 No abstract available.
-
[Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].Ugeskr Laeger. 2004 Mar 8;166(11):997-1002. Ugeskr Laeger. 2004. PMID: 15049234 Review. Danish. No abstract available.
-
Efficacy and safety of drotrecogin alfa (activated) for the therapy of surgical patients with severe sepsis.Surg Infect (Larchmt). 2006;7 Suppl 2:S77-80. doi: 10.1089/sur.2006.7.s2-77. Surg Infect (Larchmt). 2006. PMID: 16895513 Review.
Cited by
-
Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury.Nat Rev Nephrol. 2009 Nov;5(11):629-40. doi: 10.1038/nrneph.2009.155. Epub 2009 Sep 29. Nat Rev Nephrol. 2009. PMID: 19786992 Review.
-
[Guidelines for the management of community pneumonia in adult who needs hospitalization].Med Intensiva. 2005 Feb;29(1):21-62. doi: 10.1016/S0210-5691(05)74199-1. Epub 2009 Jan 6. Med Intensiva. 2005. PMID: 38620135 Free PMC article. Spanish.
-
Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?Crit Care. 2006;10(3):145. doi: 10.1186/cc4947. Epub 2006 Jun 2. Crit Care. 2006. PMID: 16762040 Free PMC article. Review.
-
Advances in Sepsis Treatment.Curr Infect Dis Rep. 2004 Oct;6(5):354-360. doi: 10.1007/s11908-004-0033-2. Curr Infect Dis Rep. 2004. PMID: 15461885
-
An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre.Drug Saf. 2004;27(15):1253-61. doi: 10.2165/00002018-200427150-00008. Drug Saf. 2004. PMID: 15588120
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
